The Journal of Electroconvulsive Therapy has published a study that supports the use of electroconvulsive therapy (ECT) for treatment of multiple chemical sensitivities (MCS).
ECT used to be known as electroshock therapy and was used to treat depression in the days before psycho-pharmaceutical drugs. Eventually ECT fell into disrepute as some patients ended up with permanent brain damage, amnesia and cognitive dysfunction after treatment. Some later killed themselves.
Only one subject with MCS was used for this study.
"The results were described in terms of the perceived improvement of 'symptom severity and social disability.' This is quite different from measured improvements such as reduced hepatic toxicity and better liver function. The abstract does not even provide the diagnostic criteria used to determine the diagnosis; therefore, it can not be determined whether the subject truly had MCS."
Blasts of ECT will not correct the environmental toxicity that is causing MCS. They will not correct the physical symptoms that stem from MCS.